Quince Therapeutics (QNCX) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

QNCX is expected to report earnings to fall 23.08% to -10 cents per share on March 04

Quince Therapeutics QNCX Stock Earnings Reports

Q4'24

Est.

$-0.10

Q3'24

Missed

by $0.03

Q1'23

Missed

by $0.03

Q4'22

Beat

by $0.14

Q3'22

Beat

by $0.06

The last earnings report on November 13 showed earnings per share of -12 cents, missing the estimate of -10 cents. With 671.12K shares outstanding, the current market capitalization sits at 82.23M.

View a ticker or compare two or three

Compare

QNCX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For QNCX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of novel disease-modifying therapeutic for alzheimer's and other degenerative diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

611 Gateway Boulevard

Phone

+1 415 910-5717

Employees

Web

https://www.quincetx.com